Drug
Niraparib
Niraparib: highest development phase Phase 2, developed by Bayer, Zai Lab. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bayer, Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| Niraparib NCT04716686 | Phase 2 | Endometrial Carcinoma |
| Niraparib NCT03076203 | Phase 1 | Prostate Carcinoma Metastatic to the Bone |
Latest
No recent events.
Follow Niraparib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.